<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-01-01" modified="2018-01-31" version="216">
<accession>P06858</accession>
<accession>B2R5T9</accession>
<accession>Q16282</accession>
<accession>Q16283</accession>
<accession>Q96FC4</accession>
<name>LIPL_HUMAN</name>
<protein>
<recommendedName>
<fullName>Lipoprotein lipase</fullName>
<shortName>LPL</shortName>
<ecNumber evidence="13 45">3.1.1.34</ecNumber>
</recommendedName>
</protein>
<gene>
<name type="primary">LPL</name>
<name type="synonym">LIPD</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1987" name="Science" volume="235" first="1638" last="1641">
<title>Human lipoprotein lipase complementary DNA sequence.</title>
<authorList>
<person name="Wion K.L."/>
<person name="Kirchgessner T.G."/>
<person name="Lusis A.J."/>
<person name="Schotz M.C."/>
<person name="Lawn R.M."/>
</authorList>
<dbReference type="PubMed" id="3823907"/>
<dbReference type="DOI" id="10.1126/science.3823907"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Nucleic Acids Res." volume="17" first="2351" last="2352">
<title>Nucleotide sequence of human cDNA coding for a lipoprotein lipase (LPL) cloned from placental cDNA library.</title>
<authorList>
<person name="Gotoda T."/>
<person name="Senda M."/>
<person name="Gamou T."/>
<person name="Furuichi Y."/>
<person name="Oka K."/>
</authorList>
<dbReference type="PubMed" id="2701938"/>
<dbReference type="DOI" id="10.1093/nar/17.6.2351"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="6436" last="6436">
<title>DNA sequence of lipoprotein lipase cDNA cloned from human monocytic leukemia THP-1 cells.</title>
<authorList>
<person name="Takagi A."/>
<person name="Ikeda Y."/>
<person name="Yamamoto A."/>
</authorList>
<dbReference type="PubMed" id="2243796"/>
<dbReference type="DOI" id="10.1093/nar/18.21.6436"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1992" name="Gene" volume="110" first="257" last="261">
<title>The lipoprotein lipase-encoding human gene: sequence from intron-6 to intron-9 and presence in intron-7 of a 40-million-year-old Alu sequence.</title>
<authorList>
<person name="Chuat J.-C."/>
<person name="Raisonnier A."/>
<person name="Etienne J."/>
<person name="Galibert F."/>
</authorList>
<dbReference type="PubMed" id="1537564"/>
<dbReference type="DOI" id="10.1016/0378-1119(92)90658-C"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT SER-318</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT SER-318</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Mol. Cell. Biol." volume="12" first="4622" last="4633">
<title>Characterization of the human lipoprotein lipase (LPL) promoter: evidence of two cis-regulatory regions, LP-alpha and LP-beta, of importance for the differentiation-linked induction of the LPL gene during adipogenesis.</title>
<authorList>
<person name="Enerbaeck S."/>
<person name="Ohlsson B.G."/>
<person name="Samuelsson L."/>
<person name="Bjursell G."/>
</authorList>
<dbReference type="PubMed" id="1406652"/>
<dbReference type="DOI" id="10.1128/MCB.12.10.4622"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-5</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1990" name="Biochim. Biophys. Acta" volume="1044" first="20" last="25">
<title>Rapid and simple isolation procedure for lipoprotein lipase from human milk.</title>
<authorList>
<person name="Zechner R."/>
</authorList>
<dbReference type="PubMed" id="2340307"/>
<dbReference type="DOI" id="10.1016/0005-2760(90)90213-H"/>
</citation>
<scope>PROTEIN SEQUENCE OF 28-44</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>Milk</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="J. Clin. Invest." volume="107" first="1183" last="1192">
<title>Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues.</title>
<authorList>
<person name="Lutz E.P."/>
<person name="Merkel M."/>
<person name="Kako Y."/>
<person name="Melford K."/>
<person name="Radner H."/>
<person name="Breslow J.L."/>
<person name="Bensadoun A."/>
<person name="Goldberg I.J."/>
</authorList>
<dbReference type="PubMed" id="11342582"/>
<dbReference type="DOI" id="10.1172/JCI11774"/>
</citation>
<scope>HEPARIN-BINDING</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1771" first="1464" last="1468">
<title>Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.</title>
<authorList>
<person name="Gin P."/>
<person name="Beigneux A.P."/>
<person name="Davies B."/>
<person name="Young M.F."/>
<person name="Ryan R.O."/>
<person name="Bensadoun A."/>
<person name="Fong L.G."/>
<person name="Young S.G."/>
</authorList>
<dbReference type="PubMed" id="17997385"/>
<dbReference type="DOI" id="10.1016/j.bbalip.2007.10.005"/>
</citation>
<scope>INTERACTION WITH GPIHBP1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="3833" last="3847">
<title>Identification of N-linked glycoproteins in human milk by hydrophilic interaction liquid chromatography and mass spectrometry.</title>
<authorList>
<person name="Picariello G."/>
<person name="Ferranti P."/>
<person name="Mamone G."/>
<person name="Roepstorff P."/>
<person name="Addeo F."/>
</authorList>
<dbReference type="PubMed" id="18780401"/>
<dbReference type="DOI" id="10.1002/pmic.200701057"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-70</scope>
<source>
<tissue>Milk</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="4626" last="4633">
<title>Lipoprotein lipase. Molecular model based on the pancreatic lipase X-ray structure: consequences for heparin binding and catalysis.</title>
<authorList>
<person name="van Tilbeurgh H."/>
<person name="Roussel A."/>
<person name="Lalouel J.-M."/>
<person name="Cambillau C."/>
</authorList>
<dbReference type="PubMed" id="8308035"/>
</citation>
<scope>3D-STRUCTURE MODELING</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Cell Metab." volume="20" first="458" last="470">
<title>The ER-associated degradation adaptor protein Sel1L regulates LPL secretion and lipid metabolism.</title>
<authorList>
<person name="Sha H."/>
<person name="Sun S."/>
<person name="Francisco A.B."/>
<person name="Ehrhardt N."/>
<person name="Xue Z."/>
<person name="Liu L."/>
<person name="Lawrence P."/>
<person name="Mattijssen F."/>
<person name="Guber R.D."/>
<person name="Panhwar M.S."/>
<person name="Brenna J.T."/>
<person name="Shi H."/>
<person name="Xue B."/>
<person name="Kersten S."/>
<person name="Bensadoun A."/>
<person name="Peterfy M."/>
<person name="Long Q."/>
<person name="Qi L."/>
</authorList>
<dbReference type="PubMed" id="25066055"/>
<dbReference type="DOI" id="10.1016/j.cmet.2014.06.015"/>
</citation>
<scope>INTERACTION WITH SEL1L AND LMF1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1991" name="Curr. Opin. Lipidol." volume="2" first="104" last="109">
<title>Genetic variants affecting human lipoprotein and hepatic lipases.</title>
<authorList>
<person name="Hayden M.R."/>
<person name="Ma Y."/>
<person name="Brunzell J."/>
<person name="Henderson H.E."/>
</authorList>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1990" name="Am. J. Hum. Genet." volume="47" first="721" last="726">
<title>Compound heterozygote for lipoprotein lipase deficiency: Ser-->Thr244 and transition in 3' splice site of intron 2 (AG-->AA) in the lipoprotein lipase gene.</title>
<authorList>
<person name="Hata A."/>
<person name="Emi M."/>
<person name="Luc G."/>
<person name="Basdevant A."/>
<person name="Gambert P."/>
<person name="Iverius P.-H."/>
<person name="Lalouel J.-M."/>
</authorList>
<dbReference type="PubMed" id="2121025"/>
</citation>
<scope>VARIANT LPL DEFICIENCY THR-271</scope>
<scope>INVOLVEMENT IN LPL</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="5910" last="5916">
<title>Missense mutation (Gly-->Glu188) of human lipoprotein lipase imparting functional deficiency.</title>
<authorList>
<person name="Emi M."/>
<person name="Wilson D.E."/>
<person name="Iverius P.H."/>
<person name="Wiu L."/>
<person name="Hata A."/>
<person name="Hegele R."/>
<person name="Williams R.R."/>
<person name="Lalouel J.-M."/>
</authorList>
<dbReference type="PubMed" id="1969408"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLU-215</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1990" name="J. Clin. Invest." volume="86" first="728" last="734">
<title>A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries.</title>
<authorList>
<person name="Monsalve M.V."/>
<person name="Henderson H."/>
<person name="Roederer G."/>
<person name="Julien P."/>
<person name="Deeb S."/>
<person name="Kastelein J.J.P."/>
<person name="Peritz L."/>
<person name="Devlin R."/>
<person name="Bruin T."/>
<person name="Murthy M.R.V."/>
<person name="Gagne C."/>
<person name="Davignon J."/>
<person name="Lupien P.J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="1975597"/>
<dbReference type="DOI" id="10.1172/JCI114769"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLU-215</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1990" name="Proc. Natl. Acad. Sci. U.S.A." volume="87" first="3474" last="3478">
<title>Lipoprotein lipase Bethesda: a single amino acid substitution (Ala-176-->Thr) leads to abnormal heparin binding and loss of enzymic activity.</title>
<authorList>
<person name="Beg O.U."/>
<person name="Meng M.S."/>
<person name="Skarlatos S.I."/>
<person name="Previato L."/>
<person name="Brunzell J.D."/>
<person name="Brewer H.B. Jr."/>
<person name="Fojo S.S."/>
</authorList>
<dbReference type="PubMed" id="2110364"/>
<dbReference type="DOI" id="10.1073/pnas.87.9.3474"/>
</citation>
<scope>VARIANT LPL DEFICIENCY THR-203</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="473" last="477">
<title>Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome.</title>
<authorList>
<person name="Dichek H.L."/>
<person name="Fojo S.S."/>
<person name="Beg O.U."/>
<person name="Skarlatos S.I."/>
<person name="Brunzell J.D."/>
<person name="Cutler G.B. Jr."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="1702428"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY THR-221 AND HIS-270</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="14418" last="14424">
<title>Catalytic triad residue mutation (Asp156-->Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447-->Ter) in a Turkish family.</title>
<authorList>
<person name="Faustinella F."/>
<person name="Chang A."/>
<person name="van Biervliet J.P."/>
<person name="Rosseneu M."/>
<person name="Vinaimont N."/>
<person name="Smith L.C."/>
<person name="Chen S.-H."/>
<person name="Chan L."/>
</authorList>
<dbReference type="PubMed" id="1907278"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLY-183</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="1165" last="1170">
<title>Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.</title>
<authorList>
<person name="Ameis D."/>
<person name="Kobayashi J."/>
<person name="Davis R.C."/>
<person name="Ben-Zeev O."/>
<person name="Malloy M.J."/>
<person name="Kane J.P."/>
<person name="Lee G."/>
<person name="Wong H."/>
<person name="Havel R.J."/>
<person name="Schotz M.C."/>
</authorList>
<dbReference type="PubMed" id="2010533"/>
<dbReference type="DOI" id="10.1172/JCI115114"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLU-169</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="87" first="2005" last="2011">
<title>Amino acid substitution (Ile194-->Thr) in exon 5 of the lipoprotein lipase gene causes lipoprotein lipase deficiency in three unrelated probands. Support for a multicentric origin.</title>
<authorList>
<person name="Henderson H.E."/>
<person name="Ma Y."/>
<person name="Hassan F."/>
<person name="Monsalve M.V."/>
<person name="Marais A.D."/>
<person name="Winkler F."/>
<person name="Gubernator K."/>
<person name="Peterson J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="1674945"/>
<dbReference type="DOI" id="10.1172/JCI115229"/>
</citation>
<scope>VARIANT LPL DEFICIENCY THR-221</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="88" first="1856" last="1864">
<title>Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency.</title>
<authorList>
<person name="Gotoda T."/>
<person name="Yamada N."/>
<person name="Kawamura M."/>
<person name="Kozaki K."/>
<person name="Mori N."/>
<person name="Ishibashi S."/>
<person name="Shimano H."/>
<person name="Takaku F."/>
<person name="Yazaki Y."/>
<person name="Furuichi Y."/>
<person name="Murase T."/>
</authorList>
<dbReference type="PubMed" id="1752947"/>
<dbReference type="DOI" id="10.1172/JCI115507"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLU-231 AND HIS-270</scope>
<scope>CHARACTERIZATION OF VARIANTS LPL DEFICIENCY GLU-231 AND HIS-270</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1991" name="N. Engl. J. Med." volume="324" first="1761" last="1766">
<title>A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.</title>
<authorList>
<person name="Ma Y."/>
<person name="Henderson H.E."/>
<person name="Ven Murthy M.R."/>
<person name="Roederer G."/>
<person name="Monsalve M.V."/>
<person name="Clarke L.A."/>
<person name="Normand T."/>
<person name="Julien P."/>
<person name="Gagne C."/>
<person name="Lambert M."/>
<person name="Davignon J."/>
<person name="Lupien P.J."/>
<person name="Brunzell J."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="2038366"/>
<dbReference type="DOI" id="10.1056/NEJM199106203242502"/>
</citation>
<scope>VARIANT LPL DEFICIENCY LEU-234</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1992" name="Am. J. Hum. Genet." volume="50" first="1275" last="1280">
<title>A missense mutation (Trp86-->Arg) in exon 3 of the lipoprotein lipase gene: a cause of familial chylomicronemia.</title>
<authorList>
<person name="Ishimura-Oka K."/>
<person name="Faustinella F."/>
<person name="Kihara S."/>
<person name="Smith L.C."/>
<person name="Oka K."/>
<person name="Chan L."/>
</authorList>
<dbReference type="PubMed" id="1598907"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ARG-113</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1992" name="Eur. J. Biochem." volume="208" first="267" last="272">
<title>A missense mutation Pro157Arg in lipoprotein lipase (LPLNijmegen) resulting in loss of catalytic activity.</title>
<authorList>
<person name="Bruin T."/>
<person name="Kastelein J.J."/>
<person name="van Diermen D.E."/>
<person name="Ma Y."/>
<person name="Henderson H.E."/>
<person name="Stuyt P.M."/>
<person name="Stalenhoef A.F.H."/>
<person name="Sturk A."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="1521525"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1992.tb17182.x"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ARG-184</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1992" name="Genomics" volume="13" first="649" last="653">
<title>A missense mutation (Asp250-->Asn) in exon 6 of the human lipoprotein lipase gene causes chylomicronemia in patients of different ancestries.</title>
<authorList>
<person name="Ma Y."/>
<person name="Wilson B.I."/>
<person name="Bijvoet S."/>
<person name="Henderson H.E."/>
<person name="Cramb E."/>
<person name="Roederer G."/>
<person name="Ven Murthy M.R."/>
<person name="Julien P."/>
<person name="Bakker H.D."/>
<person name="Kastelein J.J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="1639392"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90136-G"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ASN-277</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="1918" last="1923">
<title>Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysis.</title>
<authorList>
<person name="Ma Y.H."/>
<person name="Bruin T."/>
<person name="Tuzgol S."/>
<person name="Wilson B.I."/>
<person name="Roederer G."/>
<person name="Liu M.S."/>
<person name="Davignon J."/>
<person name="Kastelein J.J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="1730727"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ASN-183; GLY-183 AND SER-243</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="4161" last="4165">
<title>Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156, and His-241.</title>
<authorList>
<person name="Emmerich J."/>
<person name="Beg O.U."/>
<person name="Peterson J."/>
<person name="Previato L."/>
<person name="Brunzell J.D."/>
<person name="Brewer H.B. Jr."/>
<person name="Santamarina-Fojo S."/>
</authorList>
<dbReference type="PubMed" id="1371284"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS LPL DEFICIENCY ASN-183 AND GLY-183</scope>
<scope>MUTAGENESIS OF SER-159 AND HIS-268</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="20132" last="20139">
<title>Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization.</title>
<authorList>
<person name="Hata A."/>
<person name="Ridinger D.N."/>
<person name="Sutherland S.D."/>
<person name="Emi M."/>
<person name="Kwong L.K."/>
<person name="Shuhua J."/>
<person name="Lubbers A."/>
<person name="Guy-Grand B."/>
<person name="Basdevant A."/>
<person name="Iverius P.H."/>
<person name="Wilson D.E."/>
<person name="Lalouel J.-M."/>
</authorList>
<dbReference type="PubMed" id="1400331"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLU-222</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1992" name="J. Lipid Res." volume="33" first="745" last="754">
<title>A missense (Asp250-->Asn) mutation in the lipoprotein lipase gene in two unrelated families with familial lipoprotein lipase deficiency.</title>
<authorList>
<person name="Ishimura-Oka K."/>
<person name="Semenkovich C.F."/>
<person name="Faustinella F."/>
<person name="Goldberg I.J."/>
<person name="Shachter N."/>
<person name="Smith L.C."/>
<person name="Coleman T."/>
<person name="Hide W.A."/>
<person name="Brown W.V."/>
<person name="Oka K."/>
</authorList>
<dbReference type="PubMed" id="1619366"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLU-215; HIS-270 AND ASN-277</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1992" name="J. Lipid Res." volume="33" first="1823" last="1832">
<title>Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes.</title>
<authorList>
<person name="Reina M."/>
<person name="Brunzell J.D."/>
<person name="Deeb S.S."/>
</authorList>
<dbReference type="PubMed" id="1479292"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ARG-113; ARG-163; GLU-215; THR-221 AND SER-232</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="191" first="1046" last="1054">
<title>A missense mutation (Ala334-->Thr) in exon 7 of the lipoprotein lipase gene in a case with type I hyperlipidemia.</title>
<authorList>
<person name="Kobayashi J."/>
<person name="Sasaki N."/>
<person name="Tashiro J."/>
<person name="Inadera H."/>
<person name="Saito Y."/>
<person name="Yoshida S."/>
</authorList>
<dbReference type="PubMed" id="8096693"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.1323"/>
</citation>
<scope>VARIANT LPL DEFICIENCY THR-361</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1993" name="Genomics" volume="18" first="392" last="396">
<title>A novel missense mutation in the gene for lipoprotein lipase resulting in a highly conservative amino acid substitution (Asp180-->Glu) causes familial chylomicronemia (type I hyperlipoproteinemia).</title>
<authorList>
<person name="Haubenwallner S."/>
<person name="Horl G."/>
<person name="Shachter N.S."/>
<person name="Presta E."/>
<person name="Fried S.K."/>
<person name="Hofler G."/>
<person name="Kostner G.M."/>
<person name="Breslow J.L."/>
<person name="Zechner R."/>
</authorList>
<dbReference type="PubMed" id="8288243"/>
<dbReference type="DOI" id="10.1006/geno.1993.1481"/>
</citation>
<scope>VARIANT LPL DEFICIENCY GLU-207</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="91" first="1953" last="1958">
<title>Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene.</title>
<authorList>
<person name="Ma Y."/>
<person name="Liu M.-S."/>
<person name="Ginzinger D."/>
<person name="Frohlich J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="8486765"/>
<dbReference type="DOI" id="10.1172/JCI116414"/>
</citation>
<scope>VARIANT LPL DEFICIENCY CYS-199</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1993" name="J. Clin. Invest." volume="92" first="203" last="211">
<title>Mutations in exon 3 of the lipoprotein lipase gene segregating in a family with hypertriglyceridemia, pancreatitis, and non-insulin-dependent diabetes.</title>
<authorList>
<person name="Wilson D.E."/>
<person name="Hata A."/>
<person name="Kwong L.K."/>
<person name="Lingam A."/>
<person name="Shuhua J."/>
<person name="Ridinger D.N."/>
<person name="Yeager C."/>
<person name="Kaltenborn K.C."/>
<person name="Iverius P.-H."/>
<person name="Lalouel J.-M."/>
</authorList>
<dbReference type="PubMed" id="8325986"/>
<dbReference type="DOI" id="10.1172/JCI116551"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-102</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1993" name="J. Lipid Res." volume="34" first="2109" last="2119">
<title>Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by a Gly154-->Ser substitution in lipoprotein lipase.</title>
<authorList>
<person name="Bruin T."/>
<person name="Tuzgol S."/>
<person name="van Diermen D.E."/>
<person name="Hoogerbrugge-Van der Linden N."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
<person name="Kastelein J.J."/>
</authorList>
<dbReference type="PubMed" id="8301230"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-181</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="199" first="570" last="576">
<title>A new Italian case of lipoprotein lipase deficiency: a Leu365-> Val change resulting in loss of enzyme activity.</title>
<authorList>
<person name="Chimienti G.P.G."/>
<person name="Resta F."/>
<person name="di Perma V."/>
<person name="Tarricone C."/>
<person name="Lovecchio M."/>
<person name="Collacicco A.M."/>
<person name="Capurso A."/>
</authorList>
<dbReference type="PubMed" id="8135797"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.1266"/>
</citation>
<scope>VARIANT LPL DEFICIENCY VAL-392</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="205" first="506" last="515">
<title>A naturally occurring mutation at the second base of codon asparagine 43 in the proposed N-linked glycosylation site of human lipoprotein lipase: in vivo evidence that asparagine 43 is essential for catalysis and secretion.</title>
<authorList>
<person name="Kobayashi J."/>
<person name="Inadera H."/>
<person name="Fujita Y."/>
<person name="Talley G."/>
<person name="Morisaki N."/>
<person name="Yoshida S."/>
<person name="Saito Y."/>
<person name="Fojo S.S."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="7999071"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.2694"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-70</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY SER-70</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1994" name="Hum. Mutat." volume="3" first="52" last="58">
<title>Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries.</title>
<authorList>
<person name="Ma Y."/>
<person name="Liu M.-S."/>
<person name="Chitayat D."/>
<person name="Bruin T."/>
<person name="Beisiegel U."/>
<person name="Benlian P."/>
<person name="Foubert L."/>
<person name="De Gennes J.L."/>
<person name="Funke H."/>
<person name="Forsythe I."/>
<person name="Blaichman S."/>
<person name="Papanikolaou M."/>
<person name="Erkelens D.W."/>
<person name="Kastelein J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="7906986"/>
<dbReference type="DOI" id="10.1002/humu.1380030109"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY HIS-270 AND CYS-270</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1994" name="J. Lipid Res." volume="35" first="438" last="445">
<title>A compound heterozygote for lipoprotein lipase deficiency, Val69-->Leu and Gly188-->Glu: correlation between in vitro LPL activity and clinical expression.</title>
<authorList>
<person name="Bruin T."/>
<person name="Tuzgoel S."/>
<person name="Mulder W.J."/>
<person name="van den Ende A.E."/>
<person name="Jansen H."/>
<person name="Hayden M.R."/>
<person name="Kastelein J.J.P."/>
</authorList>
<dbReference type="PubMed" id="7912254"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY LEU-96 AND GLU-215</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY LEU-96</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1994" name="J. Lipid Res." volume="35" first="1066" last="1075">
<title>High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform.</title>
<authorList>
<person name="Ma Y."/>
<person name="Ooi T.C."/>
<person name="Liu M.-S."/>
<person name="Zhang H."/>
<person name="McPherson R."/>
<person name="Edwards A.L."/>
<person name="Forsythe I.J."/>
<person name="Frohlich J."/>
<person name="Brunzell J.D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="8077845"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY CYS-199; ARG-279; THR-288 AND SER-318</scope>
<scope>CHARACTERIZATION OF VARIANTS LPL DEFICIENCY ARG-279 AND THR-288</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1994" name="J. Lipid Res." volume="35" first="1552" last="1560">
<title>A novel missense mutation in the C-terminal domain of lipoprotein lipase (Glu410-->Val) leads to enzyme inactivation and familial chylomicronemia.</title>
<authorList>
<person name="Previato L."/>
<person name="Guardamagna O."/>
<person name="Dugi K.A."/>
<person name="Ronan R."/>
<person name="Talley G.D."/>
<person name="Santamarina-Fojo S."/>
<person name="Brewer H.B. Jr."/>
</authorList>
<dbReference type="PubMed" id="7806969"/>
</citation>
<scope>VARIANT LPL DEFICIENCY VAL-437</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1995" name="Nat. Genet." volume="10" first="28" last="34">
<title>A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis.</title>
<authorList>
<person name="Reymer P.W.A."/>
<person name="Gagne E."/>
<person name="Groenemeyer B.E."/>
<person name="Zhang H."/>
<person name="Forsyth I."/>
<person name="Jansen H."/>
<person name="Seidell J.C."/>
<person name="Kromhout D."/>
<person name="Lie K.E."/>
<person name="Kastelein J.J."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="7647785"/>
<dbReference type="DOI" id="10.1038/ng0595-28"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-318</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1996" name="Biochem. Biophys. Res. Commun." volume="227" first="189" last="194">
<title>A new mutation destroying disulphide bridging in the C-terminal domain of lipoprotein lipase.</title>
<authorList>
<person name="Henderson H.E."/>
<person name="Hassan F."/>
<person name="Marais D."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="8858123"/>
<dbReference type="DOI" id="10.1006/bbrc.1996.1487"/>
</citation>
<scope>VARIANT LPL DEFICIENCY TYR-445</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY TYR-445</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1996" name="Eur. J. Clin. Invest." volume="26" first="631" last="639">
<title>Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia.</title>
<authorList>
<person name="de Bruin T.W.A."/>
<person name="Mailly F."/>
<person name="van Barlingen H.H.J.J."/>
<person name="Fisher R."/>
<person name="Castro Cabezas M."/>
<person name="Talmud P."/>
<person name="Dallinga-Thie G.M."/>
<person name="Humphries S.E."/>
</authorList>
<dbReference type="PubMed" id="8872057"/>
<dbReference type="DOI" id="10.1111/j.1365-2362.1996.tb02146.x"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-318</scope>
<scope>VARIANT ASN-36</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="381" last="383">
<title>Compound heterozygosity for a known (D250N) and a novel (E410K) missense mutation in the C-terminal domain of lipoprotein lipase causes familial chylomicronemia.</title>
<authorList>
<person name="Wiebusch H."/>
<person name="Funke H."/>
<person name="Bruin T."/>
<person name="Bucher H."/>
<person name="von Eckardstein A."/>
<person name="Kastelein J.J.P."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="8956048"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:4&lt;381::AID-HUMU16>3.0.CO;2-Z"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ASN-277 AND LYS-437</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="8" first="392" last="392">
<title>A novel missense (E163G) mutation in the catalytic subunit of lipoprotein lipase causes familial chylomicronemia.</title>
<authorList>
<person name="Wiebusch H."/>
<person name="Funke H."/>
<person name="Santer R."/>
<person name="Richter W."/>
<person name="Assmann G."/>
</authorList>
<dbReference type="PubMed" id="8956052"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)8:4&lt;392::AID-HUMU20>3.0.CO;2-X"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLY-190 AND GLU-215</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1996" name="J. Lipid Res." volume="37" first="651" last="661">
<title>Homozygosity for two point mutations in the lipoprotein lipase (LPL) gene in a patient with familial LPL deficiency: LPL(Asp9-->Asn, Tyr262-->His).</title>
<authorList>
<person name="Rouis M."/>
<person name="Lohse P."/>
<person name="Dugi K.A."/>
<person name="Lohse P."/>
<person name="Beg O.U."/>
<person name="Ronan R."/>
<person name="Talley G.D."/>
<person name="Brunzell J.D."/>
<person name="Santamarina-Fojo S."/>
</authorList>
<dbReference type="PubMed" id="8728326"/>
</citation>
<scope>VARIANT LPL DEFICIENCY HIS-289</scope>
<scope>VARIANT ASN-36</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY HIS-289</scope>
<scope>CHARACTERIZATION OF VARIANT ASN-36</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1996" name="N. Engl. J. Med." volume="335" first="848" last="854">
<title>Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene.</title>
<authorList>
<person name="Benlian P."/>
<person name="De Gennes J.L."/>
<person name="Foubert L."/>
<person name="Zhang H."/>
<person name="Gagne S.E."/>
<person name="Hayden M."/>
</authorList>
<dbReference type="PubMed" id="8778602"/>
<dbReference type="DOI" id="10.1056/NEJM199609193351203"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ALA-128; GLU-215; ARG-215; CYS-270; ASN-277 AND PRO-313</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="10" first="179" last="185">
<title>A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry.</title>
<authorList>
<person name="Foubert L."/>
<person name="Bruin T."/>
<person name="de Gennes J.-L."/>
<person name="Ehrenborg E."/>
<person name="Furioli J."/>
<person name="Kastelein J.J."/>
<person name="Benlian P."/>
<person name="Hayden M.R."/>
</authorList>
<dbReference type="PubMed" id="9298816"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)10:3&lt;179::AID-HUMU1>3.3.CO;2-N"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ARG-286</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1997" name="Hum. Mutat." volume="10" first="465" last="473">
<title>Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy.</title>
<authorList>
<person name="Mailly F."/>
<person name="Palmen J."/>
<person name="Muller D.P.R."/>
<person name="Gibbs T."/>
<person name="Lloyd J."/>
<person name="Brunzell J."/>
<person name="Durrington P."/>
<person name="Mitropoulos K."/>
<person name="Betteridge J."/>
<person name="Watts G."/>
<person name="Lithell H."/>
<person name="Angelico F."/>
<person name="Humphries S.E."/>
<person name="Talmud P.J."/>
</authorList>
<dbReference type="PubMed" id="9401010"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1997)10:6&lt;465::AID-HUMU8>3.3.CO;2-3"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1997" name="J. Med. Genet." volume="34" first="672" last="675">
<title>Assessment of French patients with LPL deficiency for French Canadian mutations.</title>
<authorList>
<person name="Foubert L."/>
<person name="De Gennes J.L."/>
<person name="Lagarde J.P."/>
<person name="Ehrenborg E."/>
<person name="Raisonnier A."/>
<person name="Girardet J.P."/>
<person name="Hayden M.R."/>
<person name="Benlian P."/>
</authorList>
<dbReference type="PubMed" id="9279761"/>
<dbReference type="DOI" id="10.1136/jmg.34.8.672"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ALA-128; HIS-183; GLU-215; ARG-215; LEU-234; CYS-270 AND ASN-277</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="Am. J. Med. Genet." volume="78" first="313" last="316">
<title>Ile225Thr loop mutation in the lipoprotein lipase (LPL) gene is a de novo event.</title>
<authorList>
<person name="Henderson H.E."/>
<person name="Bijvoet S.M."/>
<person name="Mannens M.A.M.M."/>
<person name="Bruin T."/>
<person name="Erkelens D.W."/>
<person name="Hayden M.R."/>
<person name="Kastelein J.J.P."/>
</authorList>
<dbReference type="PubMed" id="9714430"/>
<dbReference type="DOI" id="10.1002/(SICI)1096-8628(19980724)78:4&lt;313::AID-AJMG1>3.0.CO;2-M"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY THR-252 AND HIS-270</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1998" name="Clin. Chim. Acta" volume="269" first="1" last="12">
<title>A novel Glu421Lys substitution in the lipoprotein lipase gene in pregnancy-induced hypertriglyceridemic pancreatitis.</title>
<authorList>
<person name="Henderson H."/>
<person name="Leisegang F."/>
<person name="Hassan F."/>
<person name="Hayden M."/>
<person name="Marais D."/>
</authorList>
<dbReference type="PubMed" id="9498099"/>
<dbReference type="DOI" id="10.1016/S0009-8981(97)00144-7"/>
</citation>
<scope>VARIANT LPL DEFICIENCY LYS-448</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY LYS-448</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="217" last="217">
<title>Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LPL) as a cause of chylomicronemia.</title>
<authorList>
<person name="Evans D."/>
<person name="Wendt D."/>
<person name="Ahle S."/>
<person name="Guerra A."/>
<person name="Beisiegel U."/>
</authorList>
<dbReference type="PubMed" id="10660334"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLU-215 AND GLY-286</scope>
</reference>
<reference key="59">
<citation type="journal article" date="1998" name="Mol. Genet. Metab." volume="64" first="177" last="183">
<title>Common genetic variants of lipoprotein lipase and apolipoproteins AI-CIII that relate to coronary artery disease: a study in Chinese and European subjects.</title>
<authorList>
<person name="Zhang Q."/>
<person name="Liu Y."/>
<person name="Liu B.W."/>
<person name="Fan P."/>
<person name="Cavanna J."/>
<person name="Galton D.J."/>
</authorList>
<dbReference type="PubMed" id="9719626"/>
<dbReference type="DOI" id="10.1006/mgme.1998.2712"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY THR-288 AND SER-318</scope>
<scope>VARIANT ASN-36</scope>
</reference>
<reference key="60">
<citation type="journal article" date="1998" name="Nat. Genet." volume="19" first="233" last="240">
<title>DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene.</title>
<authorList>
<person name="Nickerson D.A."/>
<person name="Taylor S.L."/>
<person name="Weiss K.M."/>
<person name="Clark A.G."/>
<person name="Hutchinson R.G."/>
<person name="Stengaerd J."/>
<person name="Salomaa V."/>
<person name="Vartiainen E."/>
<person name="Boerwinkle E."/>
<person name="Sing C.F."/>
</authorList>
<dbReference type="PubMed" id="9662394"/>
<dbReference type="DOI" id="10.1038/907"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-318</scope>
<scope>VARIANTS MET-370 AND ALA-379</scope>
</reference>
<reference key="61">
<citation type="journal article" date="1999" name="Nat. Genet." volume="22" first="231" last="238">
<title>Characterization of single-nucleotide polymorphisms in coding regions of human genes.</title>
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="10391209"/>
<dbReference type="DOI" id="10.1038/10290"/>
</citation>
<scope>VARIANT THR-427</scope>
</reference>
<reference key="62">
<citation type="journal article" date="1999" name="Nat. Genet." volume="23" first="373" last="373">
<authorList>
<person name="Cargill M."/>
<person name="Altshuler D."/>
<person name="Ireland J."/>
<person name="Sklar P."/>
<person name="Ardlie K."/>
<person name="Patil N."/>
<person name="Shaw N."/>
<person name="Lane C.R."/>
<person name="Lim E.P."/>
<person name="Kalyanaraman N."/>
<person name="Nemesh J."/>
<person name="Ziaugra L."/>
<person name="Friedland L."/>
<person name="Rolfe A."/>
<person name="Warrington J."/>
<person name="Lipshutz R."/>
<person name="Daley G.Q."/>
<person name="Lander E.S."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2000" name="Biochim. Biophys. Acta" volume="1502" first="433" last="446">
<title>A newly identified lipoprotein lipase (LPL) gene mutation (F270L) in a Japanese patient with familial LPL deficiency.</title>
<authorList>
<person name="Takagi A."/>
<person name="Ikeda Y."/>
<person name="Takeda E."/>
<person name="Yamamoto A."/>
</authorList>
<dbReference type="PubMed" id="11068186"/>
<dbReference type="DOI" id="10.1016/S0925-4439(00)00067-3"/>
</citation>
<scope>VARIANT LPL DEFICIENCY LEU-297</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY LEU-297</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2000" name="Clin. Sci." volume="99" first="569" last="578">
<title>A compound heterozygote for a novel missense mutation (G105R) in exon 3 and a missense mutation (D204E) in exon 5 of the lipoprotein lipase gene in a Japanese infant with hyperchylomicronaemia.</title>
<authorList>
<person name="Ikeda Y."/>
<person name="Goji K."/>
<person name="Takagi A."/>
</authorList>
<dbReference type="PubMed" id="11099402"/>
<dbReference type="DOI" id="10.1042/cs0990569"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY ARG-132 AND GLU-231</scope>
<scope>CHARACTERIZATION OF VARIANTS LPL DEFICIENCY ARG-132 AND GLU-231</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2000" name="J. Clin. Endocrinol. Metab." volume="85" first="4795" last="4798">
<title>Type I hyperlipoproteinemia due to a novel loss of function mutation of lipoprotein lipase, Cys(239)-->Trp, associated with recurrent severe pancreatitis.</title>
<authorList>
<person name="Hoffmann M.M."/>
<person name="Jacob S."/>
<person name="Luft D."/>
<person name="Schmuelling R.-M."/>
<person name="Rett K."/>
<person name="Maerz W."/>
<person name="Haering H.-U."/>
<person name="Matthaei S."/>
</authorList>
<dbReference type="PubMed" id="11134145"/>
<dbReference type="DOI" id="10.1210/jcem.85.12.7069"/>
</citation>
<scope>VARIANT LPL DEFICIENCY TRP-266</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2000" name="J. Lipid Res." volume="41" first="734" last="741">
<title>Two novel mutations in the lipoprotein lipase gene in a family with marked hypertriglyceridemia in heterozygous carriers. Potential interaction with the polymorphic marker D1S104 on chromosome 1q21-q23.</title>
<authorList>
<person name="Hoelzl B."/>
<person name="Kraft H.G."/>
<person name="Wiebusch H."/>
<person name="Sandhofer A."/>
<person name="Patsch J."/>
<person name="Sandhofer F."/>
<person name="Paulweber B."/>
</authorList>
<dbReference type="PubMed" id="10787434"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ASP-210</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY ASP-210</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2001" name="J. Lipid Res." volume="42" first="1072" last="1081">
<title>Novel compound heterozygous mutations for lipoprotein lipase deficiency. A G-to-T transversion at the first position of exon 5 causing G154V missense mutation and a 5' splice site mutation of intron 8.</title>
<authorList>
<person name="Ikeda Y."/>
<person name="Takagi A."/>
<person name="Nakata Y."/>
<person name="Sera Y."/>
<person name="Hyoudou S."/>
<person name="Hamamoto K."/>
<person name="Nishi Y."/>
<person name="Yamamoto A."/>
</authorList>
<dbReference type="PubMed" id="11441134"/>
</citation>
<scope>VARIANT LPL DEFICIENCY VAL-181</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY VAL-181</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="232" last="233">
<title>Genotype-phenotype studies of six novel LPL mutations in Chinese patients with hypertriglyceridemia.</title>
<authorList>
<person name="Chan L.Y.S."/>
<person name="Lam C.-W."/>
<person name="Mak Y.-T."/>
<person name="Tomlinson B."/>
<person name="Tsang M.-W."/>
<person name="Baum L."/>
<person name="Masarei J.R.L."/>
<person name="Pang C.-P."/>
</authorList>
<dbReference type="PubMed" id="12204001"/>
<dbReference type="DOI" id="10.1002/humu.9054"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY THR-98; ILE-208; VAL-279; ARG-279; TYR-310; ARG-325 AND PHE-365</scope>
<scope>CHARACTERIZATION OF VARIANTS LPL DEFICIENCY THR-98; ILE-208; VAL-279; ARG-279; TYR-310; ARG-325 AND PHE-365</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2003" name="Eur. J. Clin. Invest." volume="33" first="216" last="222">
<title>Novel LPL mutation (L303F) found in a patient associated with coronary artery disease and severe systemic atherosclerosis.</title>
<authorList>
<person name="Saika Y."/>
<person name="Sakai N."/>
<person name="Takahashi M."/>
<person name="Maruyama T."/>
<person name="Kihara S."/>
<person name="Ouchi N."/>
<person name="Ishigami M."/>
<person name="Hiraoka H."/>
<person name="Nakamura T."/>
<person name="Yamashita S."/>
<person name="Matsuzawa Y."/>
</authorList>
<dbReference type="PubMed" id="12641539"/>
<dbReference type="DOI" id="10.1046/j.1365-2362.2003.01129.x"/>
</citation>
<scope>VARIANT LPL DEFICIENCY PHE-303</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY PHE-303</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2733" last="2743">
<title>Association of extreme blood lipid profile phenotypic variation with 11 reverse cholesterol transport genes and 10 non-genetic cardiovascular disease risk factors.</title>
<authorList>
<person name="Morabia A."/>
<person name="Cayanis E."/>
<person name="Costanza M.C."/>
<person name="Ross B.M."/>
<person name="Flaherty M.S."/>
<person name="Alvin G.B."/>
<person name="Das K."/>
<person name="Gilliam T.C."/>
</authorList>
<dbReference type="PubMed" id="12966036"/>
<dbReference type="DOI" id="10.1093/hmg/ddg314"/>
</citation>
<scope>VARIANT LPL DEFICIENCY SER-318</scope>
<scope>VARIANT ASN-36</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2004" name="Clin. Genet." volume="65" first="158" last="161">
<title>Identification of the first Lebanese mutation in the LPL gene and description of a rapid detection method.</title>
<authorList>
<person name="Abifadel M."/>
<person name="Jambart S."/>
<person name="Allard D."/>
<person name="Rabes J.-P."/>
<person name="Varret M."/>
<person name="Derre A."/>
<person name="Chouery E."/>
<person name="Salem N."/>
<person name="Junien C."/>
<person name="Aydenian H."/>
<person name="Boileau C."/>
</authorList>
<dbReference type="PubMed" id="14984478"/>
<dbReference type="DOI" id="10.1111/j.0009-9163.2004.00205.x"/>
</citation>
<scope>VARIANT LPL DEFICIENCY VAL-201</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2004" name="Eur. J. Pediatr." volume="163" first="462" last="466">
<title>Severe hypertriglyceridaemia in a Greek infant: a clinical, biochemical and genetic study.</title>
<authorList>
<person name="Kavazarakis E."/>
<person name="Stabouli S."/>
<person name="Gourgiotis D."/>
<person name="Roumeliotou K."/>
<person name="Traeger-Synodinos J."/>
<person name="Bossios A."/>
<person name="Fretzayas A."/>
<person name="Kanavakis E."/>
</authorList>
<dbReference type="PubMed" id="15185149"/>
<dbReference type="DOI" id="10.1007/s00431-004-1474-1"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLU-215 AND ARG-328</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2004" name="J. Atheroscler. Thromb." volume="11" first="131" last="145">
<title>Mutations in Japanese subjects with primary hyperlipidemia -- results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996.</title>
<authorList>
<consortium name="The research committee on primary hyperlipidemia of the ministry of health and welfare of Japan"/>
<person name="Maruyama T."/>
<person name="Yamashita S."/>
<person name="Matsuzawa Y."/>
<person name="Bujo H."/>
<person name="Takahashi K."/>
<person name="Saito Y."/>
<person name="Ishibashi S."/>
<person name="Ohashi K."/>
<person name="Shionoiri F."/>
<person name="Gotoda T."/>
<person name="Yamada N."/>
<person name="Kita T."/>
</authorList>
<dbReference type="PubMed" id="15256764"/>
<dbReference type="DOI" id="10.5551/jat.11.131"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY SER-70; ARG-132; VAL-181; GLU-215; THR-221; ARG-225; ALA-227; GLU-231; CYS-270; HIS-270; THR-288; LEU-297; ARG-305; PHE-330 AND THR-361</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2005" name="J. Inherit. Metab. Dis." volume="28" first="137" last="140">
<title>Hyperchylomicronaemia due to lipoprotein lipase deficiency as a cause of false-positive newborn screening for biotinidase deficiency.</title>
<authorList>
<person name="Santer R."/>
<person name="Gokcay G."/>
<person name="Demirkol M."/>
<person name="Gal A."/>
<person name="Lukacs Z."/>
</authorList>
<dbReference type="PubMed" id="15877202"/>
<dbReference type="DOI" id="10.1007/s10545-005-7060-5"/>
</citation>
<scope>VARIANTS LPL DEFICIENCY GLU-186; GLU-215 AND THR-221</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2016" name="J. Clin. Lipidol." volume="10" first="816" last="823">
<title>Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia.</title>
<authorList>
<person name="Pingitore P."/>
<person name="Lepore S.M."/>
<person name="Pirazzi C."/>
<person name="Mancina R.M."/>
<person name="Motta B.M."/>
<person name="Valenti L."/>
<person name="Berge K.E."/>
<person name="Retterstoel K."/>
<person name="Leren T.P."/>
<person name="Wiklund O."/>
<person name="Romeo S."/>
</authorList>
<dbReference type="PubMed" id="27578112"/>
<dbReference type="DOI" id="10.1016/j.jacl.2016.02.015"/>
</citation>
<scope>VARIANT LPL DEFICIENCY ARG-404</scope>
<scope>CHARACTERIZATION OF VARIANT LPL DEFICIENCY ARG-404</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<comment type="function">
<text evidence="1 13 45">The primary function of this lipase is the hydrolysis of triglycerides of circulating chylomicrons and very low density lipoproteins (VLDL) (PubMed:27578112). Binding to heparin sulfate proteogylcans at the cell surface is vital to the function. The apolipoprotein, APOC2, acts as a coactivator of LPL activity in the presence of lipids on the luminal surface of vascular endothelium (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="13 45">Triacylglycerol + H(2)O = diacylglycerol + a carboxylate.</text>
</comment>
<comment type="subunit">
<text evidence="2 3 34 44">Homodimer (By similarity). Interacts with APOC2; the interaction activates LPL activity in the presence of lipids (By similarity). Interacts with GPIHBP1 (PubMed:17997385). Interacts with SEL1L and LMF1 (PubMed:25066055).</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="1">Cell membrane</location>
<topology evidence="1">Lipid-anchor</topology>
<topology evidence="1">GPI-anchor</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="43 45">Secreted</location>
</subcellularLocation>
<text evidence="1">Locates to the plasma membrane of microvilli of hepatocytes with triacyl-glycerol-rich lipoproteins (TRL). Some of the bound LPL is then internalized and located inside non-coated endocytic vesicles (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="4">Tyrosine nitration after lipopolysaccharide (LPS) challenge down-regulates the lipase activity.</text>
</comment>
<comment type="disease" evidence="8 9 10 11 12 14 15 16 17 19 20 21 22 23 24 26 27 28 29 30 31 32 33 36 37 38 39 40 41 42 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69">
<disease id="DI-01911">
<name>Lipoprotein lipase deficiency</name>
<acronym>LPL deficiency</acronym>
<description>Recessive disorder usually manifesting in childhood. On a normal diet, patients often present with abdominal pain, hepatosplenomegaly, lipemia retinalis, eruptive xanthomata, and massive hypertriglyceridemia, sometimes complicated with acute pancreatitis.</description>
<dbReference type="MIM" id="238600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="71">Belongs to the AB hydrolase superfamily. Lipase family.</text>
</comment>
<comment type="online information" name="SHMPD">
<link uri="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&amp;genename=LPL"/>
<text>The Singapore human mutation and polymorphism database</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Lipoprotein_lipase"/>
<text>Lipoprotein lipase entry</text>
</comment>
<dbReference type="EC" id="3.1.1.34" evidence="13 45"/>
<dbReference type="EMBL" id="M15856">
<property type="protein sequence ID" value="AAB59536.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X14390">
<property type="protein sequence ID" value="CAA32564.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X54516">
<property type="protein sequence ID" value="CAA38372.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M76722">
<property type="protein sequence ID" value="AAA59528.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76076">
<property type="protein sequence ID" value="AAB21000.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S76077">
<property type="protein sequence ID" value="AAB20999.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BT006726">
<property type="protein sequence ID" value="AAP35372.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312311">
<property type="protein sequence ID" value="BAG35236.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471080">
<property type="protein sequence ID" value="EAW63764.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC011353">
<property type="protein sequence ID" value="AAH11353.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X68111">
<property type="protein sequence ID" value="CAA48230.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6012.1"/>
<dbReference type="PIR" id="A26082">
<property type="entry name" value="LIHUL"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000228.1">
<property type="nucleotide sequence ID" value="NM_000237.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.180878"/>
<dbReference type="ProteinModelPortal" id="P06858"/>
<dbReference type="SMR" id="P06858"/>
<dbReference type="BioGrid" id="110205">
<property type="interactions" value="19"/>
</dbReference>
<dbReference type="IntAct" id="P06858">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-1369348"/>
<dbReference type="STRING" id="9606.ENSP00000309757"/>
<dbReference type="BindingDB" id="P06858"/>
<dbReference type="ChEMBL" id="CHEMBL2060"/>
<dbReference type="DrugBank" id="DB09278">
<property type="generic name" value="Activated charcoal"/>
</dbReference>
<dbReference type="DrugBank" id="DB06439">
<property type="generic name" value="Tyloxapol"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000000568"/>
<dbReference type="ESTHER" id="human-LPL">
<property type="family name" value="Lipoprotein_Lipase"/>
</dbReference>
<dbReference type="iPTMnet" id="P06858"/>
<dbReference type="PhosphoSitePlus" id="P06858"/>
<dbReference type="BioMuta" id="LPL"/>
<dbReference type="DMDM" id="126314"/>
<dbReference type="EPD" id="P06858"/>
<dbReference type="MaxQB" id="P06858"/>
<dbReference type="PaxDb" id="P06858"/>
<dbReference type="PeptideAtlas" id="P06858"/>
<dbReference type="PRIDE" id="P06858"/>
<dbReference type="DNASU" id="4023"/>
<dbReference type="Ensembl" id="ENST00000311322">
<property type="protein sequence ID" value="ENSP00000309757"/>
<property type="gene ID" value="ENSG00000175445"/>
</dbReference>
<dbReference type="GeneID" id="4023"/>
<dbReference type="KEGG" id="hsa:4023"/>
<dbReference type="UCSC" id="uc003wzk.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4023"/>
<dbReference type="DisGeNET" id="4023"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000175445.14"/>
<dbReference type="GeneCards" id="LPL"/>
<dbReference type="GeneReviews" id="LPL"/>
<dbReference type="HGNC" id="HGNC:6677">
<property type="gene designation" value="LPL"/>
</dbReference>
<dbReference type="HPA" id="HPA048749"/>
<dbReference type="MalaCards" id="LPL"/>
<dbReference type="MIM" id="238600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="609708">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P06858"/>
<dbReference type="OpenTargets" id="ENSG00000175445"/>
<dbReference type="Orphanet" id="309015">
<property type="disease" value="Familial lipoprotein lipase deficiency"/>
</dbReference>
<dbReference type="Orphanet" id="70470">
<property type="disease" value="Hyperlipoproteinemia type 5"/>
</dbReference>
<dbReference type="PharmGKB" id="PA232"/>
<dbReference type="eggNOG" id="ENOG410IJUA">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4111GMM">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119069"/>
<dbReference type="HOGENOM" id="HOG000038553"/>
<dbReference type="HOVERGEN" id="HBG002259"/>
<dbReference type="InParanoid" id="P06858"/>
<dbReference type="KO" id="K01059"/>
<dbReference type="OMA" id="FHYQVKI"/>
<dbReference type="OrthoDB" id="EOG091G052B"/>
<dbReference type="PhylomeDB" id="P06858"/>
<dbReference type="TreeFam" id="TF324997"/>
<dbReference type="BRENDA" id="3.1.1.34">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963889">
<property type="pathway name" value="Assembly of active LPL and LIPC lipase complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963901">
<property type="pathway name" value="Chylomicron remodeling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975634">
<property type="pathway name" value="Retinoid metabolism and transport"/>
</dbReference>
<dbReference type="SIGNOR" id="P06858"/>
<dbReference type="GeneWiki" id="Lipoprotein_lipase"/>
<dbReference type="GenomeRNAi" id="4023"/>
<dbReference type="PRO" id="PR:P06858"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000175445"/>
<dbReference type="CleanEx" id="HS_LPL"/>
<dbReference type="ExpressionAtlas" id="P06858">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P06858">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0031225">
<property type="term" value="C:anchored component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042627">
<property type="term" value="C:chylomicron"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031012">
<property type="term" value="C:extracellular matrix"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0034361">
<property type="term" value="C:very-low-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0034185">
<property type="term" value="F:apolipoprotein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004465">
<property type="term" value="F:lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004620">
<property type="term" value="F:phospholipase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005102">
<property type="term" value="F:receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0017129">
<property type="term" value="F:triglyceride binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004806">
<property type="term" value="F:triglyceride lipase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034371">
<property type="term" value="P:chylomicron remodeling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006633">
<property type="term" value="P:fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055096">
<property type="term" value="P:low-density lipoprotein particle mediated signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006644">
<property type="term" value="P:phospholipid metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090197">
<property type="term" value="P:positive regulation of chemokine secretion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010886">
<property type="term" value="P:positive regulation of cholesterol storage"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010744">
<property type="term" value="P:positive regulation of macrophage derived foam cell differentiation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010890">
<property type="term" value="P:positive regulation of sequestering of triglyceride"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051004">
<property type="term" value="P:regulation of lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0009409">
<property type="term" value="P:response to cold"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009749">
<property type="term" value="P:response to glucose"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0001523">
<property type="term" value="P:retinoid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019432">
<property type="term" value="P:triglyceride biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019433">
<property type="term" value="P:triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006641">
<property type="term" value="P:triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034372">
<property type="term" value="P:very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd00707">
<property type="entry name" value="Pancreat_lipase_like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.60.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.50.1820">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029058">
<property type="entry name" value="AB_hydrolase"/>
</dbReference>
<dbReference type="InterPro" id="IPR013818">
<property type="entry name" value="Lipase/vitellogenin"/>
</dbReference>
<dbReference type="InterPro" id="IPR016272">
<property type="entry name" value="Lipase_LIPH"/>
</dbReference>
<dbReference type="InterPro" id="IPR033906">
<property type="entry name" value="Lipase_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR002330">
<property type="entry name" value="Lipo_Lipase"/>
</dbReference>
<dbReference type="InterPro" id="IPR001024">
<property type="entry name" value="PLAT/LH2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036392">
<property type="entry name" value="PLAT/LH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000734">
<property type="entry name" value="TAG_lipase"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11610">
<property type="entry name" value="PTHR11610"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11610:SF3">
<property type="entry name" value="PTHR11610:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00151">
<property type="entry name" value="Lipase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01477">
<property type="entry name" value="PLAT"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000865">
<property type="entry name" value="Lipoprotein_lipase_LIPH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00822">
<property type="entry name" value="LIPOLIPASE"/>
</dbReference>
<dbReference type="PRINTS" id="PR00821">
<property type="entry name" value="TAGLIPASE"/>
</dbReference>
<dbReference type="SMART" id="SM00308">
<property type="entry name" value="LH2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF49723">
<property type="entry name" value="SSF49723"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53474">
<property type="entry name" value="SSF53474"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR03230">
<property type="entry name" value="lipo_lipase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00120">
<property type="entry name" value="LIPASE_SER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50095">
<property type="entry name" value="PLAT"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0162">Chylomicron</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0336">GPI-anchor</keyword>
<keyword id="KW-0358">Heparin-binding</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0380">Hyperlipidemia</keyword>
<keyword id="KW-0442">Lipid degradation</keyword>
<keyword id="KW-0443">Lipid metabolism</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0944">Nitration</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0850">VLDL</keyword>
<feature type="signal peptide" evidence="43">
<location>
<begin position="1"/>
<end position="27"/>
</location>
</feature>
<feature type="chain" description="Lipoprotein lipase" id="PRO_0000017775">
<location>
<begin position="28"/>
<end position="475"/>
</location>
</feature>
<feature type="domain" description="PLAT" evidence="6">
<location>
<begin position="341"/>
<end position="464"/>
</location>
</feature>
<feature type="region of interest" description="Heparin-binding" evidence="1">
<location>
<begin position="346"/>
<end position="441"/>
</location>
</feature>
<feature type="active site" description="Nucleophile">
<location>
<position position="159"/>
</location>
</feature>
<feature type="active site" description="Charge relay system">
<location>
<position position="183"/>
</location>
</feature>
<feature type="active site" description="Charge relay system">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Nitrated tyrosine" evidence="4">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="Nitrated tyrosine" evidence="4">
<location>
<position position="191"/>
</location>
</feature>
<feature type="modified residue" description="Nitrated tyrosine" evidence="4">
<location>
<position position="343"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="35">
<location>
<position position="70"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="5">
<location>
<position position="386"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="54"/>
<end position="67"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="243"/>
<end position="266"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="291"/>
<end position="310"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="302"/>
<end position="305"/>
</location>
</feature>
<feature type="disulfide bond" evidence="6">
<location>
<begin position="445"/>
<end position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; has approximately 80% of the specific activity of wild-type enzyme; dbSNP:rs1801177." id="VAR_011948" evidence="17 58 61 69">
<original>D</original>
<variation>N</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; produces an inactive protein which is not secreted into the media." id="VAR_057914" evidence="24 50">
<original>N</original>
<variation>S</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11542065." id="VAR_049819">
<original>H</original>
<variation>Q</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; gives rise to a 80% decrease in specific catalytic activity; dbSNP:rs373088068." id="VAR_057915" evidence="49">
<original>V</original>
<variation>L</variation>
<location>
<position position="96"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreases the specific activity of the enzyme; reduces the secretion of the mutant protein significantly; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs145657341." id="VAR_057916" evidence="15">
<original>A</original>
<variation>T</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204073." id="VAR_004211" evidence="56">
<original>R</original>
<variation>S</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004212">
<original>W</original>
<variation>G</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204069." id="VAR_004213" evidence="20 27">
<original>W</original>
<variation>R</variation>
<location>
<position position="113"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057917" evidence="59 64">
<original>T</original>
<variation>A</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; synthesized as a catalytically inactive form." id="VAR_057918" evidence="11 24">
<original>G</original>
<variation>R</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004214" evidence="20">
<original>H</original>
<variation>R</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204063." id="VAR_004215" evidence="39">
<original>G</original>
<variation>E</variation>
<location>
<position position="169"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004216" evidence="55">
<original>G</original>
<variation>S</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; synthesized as a catalytically inactive form." id="VAR_057919" evidence="14 24">
<original>G</original>
<variation>V</variation>
<location>
<position position="181"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; lacks both triolein and tributyrin esterase activities; dbSNP:rs118204064." id="VAR_004217" evidence="18 32 36">
<original>D</original>
<variation>G</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs781614031." id="VAR_057920" evidence="64">
<original>D</original>
<variation>H</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; lacks both triolein and tributyrin esterase activities." id="VAR_004218" evidence="18 32">
<original>D</original>
<variation>N</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; Nijmegen; loss of activity." id="VAR_004219" evidence="23">
<original>P</original>
<variation>R</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; 3.2% of activity; dbSNP:rs748349562." id="VAR_004220">
<original>A</original>
<variation>T</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057921" evidence="26">
<original>G</original>
<variation>E</variation>
<location>
<position position="186"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057922" evidence="63">
<original>E</original>
<variation>G</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; mild hypertriglyceridemia; partial activity; dbSNP:rs118204072." id="VAR_004221" evidence="51 57">
<original>S</original>
<variation>C</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057923" evidence="21">
<original>D</original>
<variation>V</variation>
<location>
<position position="201"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; Bethesda; loss of activity and abnormal heparin binding; dbSNP:rs118204056." id="VAR_004222" evidence="41">
<original>A</original>
<variation>T</variation>
<location>
<position position="203"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204076." id="VAR_004223" evidence="54">
<original>D</original>
<variation>E</variation>
<location>
<position position="207"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreases the specific activity of the enzyme; has a mild effect on the secretion of the mutant enzyme; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs568397156." id="VAR_057924" evidence="15">
<original>V</original>
<variation>I</variation>
<location>
<position position="208"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; complete loss of enzyme activity." id="VAR_057925" evidence="9">
<original>H</original>
<variation>D</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity." id="VAR_004224">
<original>H</original>
<variation>Q</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204057." id="VAR_004225" evidence="8 20 22 24 26 28 37 38 49 59 63 64">
<original>G</original>
<variation>E</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057926" evidence="59 64">
<original>G</original>
<variation>R</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; 2.0% of activity; dbSNP:rs757546424." id="VAR_004226">
<original>S</original>
<variation>R</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204061." id="VAR_004227" evidence="20 24 26 30 31">
<original>I</original>
<variation>T</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204075." id="VAR_004228" evidence="19">
<original>G</original>
<variation>E</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057927" evidence="24">
<original>K</original>
<variation>R</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs528243561." id="VAR_057928" evidence="24">
<original>V</original>
<variation>A</variation>
<location>
<position position="227"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204067." id="VAR_004229" evidence="11 24 33">
<original>D</original>
<variation>E</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs770601263." id="VAR_004230" evidence="20">
<original>I</original>
<variation>S</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204060." id="VAR_004231" evidence="40 64">
<original>P</original>
<variation>L</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity." id="VAR_004232" evidence="32">
<original>C</original>
<variation>S</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204080." id="VAR_057929" evidence="68">
<original>I</original>
<variation>T</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204082." id="VAR_057930" evidence="12">
<original>C</original>
<variation>W</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204077." id="VAR_057931" evidence="24 48 59 64">
<original>R</original>
<variation>C</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204062." id="VAR_004233" evidence="24 28 31 33 48 68">
<original>R</original>
<variation>H</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204059." id="VAR_004234" evidence="42">
<original>S</original>
<variation>T</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; 5% of full activity; dbSNP:rs118204068." id="VAR_004235" evidence="28 29 59 62 64">
<original>D</original>
<variation>N</variation>
<location>
<position position="277"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004236">
<original>S</original>
<variation>C</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreases the specific activity of the enzyme; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs35414700." id="VAR_057932" evidence="15 51">
<original>L</original>
<variation>R</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreases the specific activity of the enzyme; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs371282890." id="VAR_057933" evidence="15">
<original>L</original>
<variation>V</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004237" evidence="8">
<original>S</original>
<variation>G</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004238" evidence="65">
<original>S</original>
<variation>R</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; the LPL mass level is approximately 67% of the normal; the activity is 32% of the nornal; dbSNP:rs1800011." id="VAR_011949" evidence="24 51 69">
<original>A</original>
<variation>T</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; no enzyme activity." id="VAR_057934" evidence="58">
<original>Y</original>
<variation>H</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency and hyperlipidemia; synthesized as a catalytically inactive form; total amount is almost equal to that of the normal enzyme; non-releasable by heparin due to the abnormal structure of the mutant protein." id="VAR_057935" evidence="10 24">
<original>F</original>
<variation>L</variation>
<location>
<position position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; approximately 6% of normal LPL activity and 40% of LPL mass are detected in the patient's postheparin plasma; results in the production of a functionally inactive enzyme." id="VAR_057936" evidence="16">
<original>L</original>
<variation>F</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs773235712." id="VAR_057937" evidence="24">
<original>C</original>
<variation>R</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreases the specific activity of the enzyme; reduces the secretion of the mutant protein significantly; the total LPL mass is reduced compared to that of the wild-type construct." id="VAR_057938" evidence="15">
<original>C</original>
<variation>Y</variation>
<location>
<position position="310"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057939" evidence="59">
<original>L</original>
<variation>P</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; frequent mutation; dbSNP:rs268." id="VAR_004239" evidence="17 25 46 51 61 67 69 70">
<original>N</original>
<variation>S</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; has no effect on the specific activity of the enzyme; has a mild effect on the secretion of the mutant enzyme; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs761265900." id="VAR_057940" evidence="15">
<original>S</original>
<variation>R</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057941" evidence="22">
<original>M</original>
<variation>R</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004240">
<original>M</original>
<variation>T</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_057942" evidence="24">
<original>L</original>
<variation>F</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004241">
<original>L</original>
<variation>P</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; dbSNP:rs118204071." id="VAR_004242" evidence="24 52">
<original>A</original>
<variation>T</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; increases the specific activity of the enzyme; has a mild effect on the secretion of the mutant enzyme; the total LPL mass is reduced compared to that of the wild-type construct; dbSNP:rs546542623." id="VAR_057943" evidence="15">
<original>S</original>
<variation>F</variation>
<location>
<position position="365"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs298." id="VAR_011950" evidence="67">
<original>V</original>
<variation>M</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs300." id="VAR_011951" evidence="67">
<original>T</original>
<variation>A</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; loss of activity; dbSNP:rs118204078." id="VAR_004243" evidence="53">
<original>L</original>
<variation>V</variation>
<location>
<position position="392"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; decreased protein secretion; loss of lipoprotein lipase activity." id="VAR_077541" evidence="45">
<original>M</original>
<variation>R</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; affects the protein folding." id="VAR_004244">
<location>
<begin position="423"/>
<end position="424"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5934." id="VAR_011952" evidence="7">
<original>A</original>
<variation>T</variation>
<location>
<position position="427"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004245" evidence="62">
<original>E</original>
<variation>K</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency." id="VAR_004246" evidence="47">
<original>E</original>
<variation>V</variation>
<location>
<position position="437"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; has 48% of normal activity in vitro; decreased levels of activity account for by the lower protein mass levels of the mutants rather than by decreased enzymatic activities; dbSNP:rs118204079." id="VAR_057944" evidence="60">
<original>C</original>
<variation>Y</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In LPL deficiency; results in a moderate reduction in catalytic activity; dbSNP:rs149089920." id="VAR_057945" evidence="66">
<original>E</original>
<variation>K</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lacks both triolein and tributyrin esterase activities." evidence="18">
<original>S</original>
<variation>G</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lacks both triolein and tributyrin esterase activities." evidence="18">
<original>S</original>
<variation>T</variation>
<location>
<position position="159"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lacks both triolein and tributyrin esterase activities." evidence="18">
<original>H</original>
<variation>G</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="mutagenesis site" description="Lacks both triolein and tributyrin esterase activities." evidence="18">
<original>H</original>
<variation>Q</variation>
<location>
<position position="268"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250"/>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11151"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P11152"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q06000"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255"/>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00152"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10391209"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10660334"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10787434"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11068186"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11099402"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11134145"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11342582"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11441134"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12204001"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12641539"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12966036"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1371284"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1400331"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1479292"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14984478"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15185149"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1521525"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15256764"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15877202"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1598907"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1619366"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1639392"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1674945"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1702428"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1730727"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1752947"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997385"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18780401"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1907278"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1969408"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1975597"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2010533"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2038366"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2110364"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2121025"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2340307"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25066055"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27578112"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7647785"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7806969"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7906986"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7912254"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7999071"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8077845"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8096693"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8135797"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8288243"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8301230"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8325986"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8486765"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8728326"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8778602"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8858123"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8872057"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8956048"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8956052"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9279761"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9298816"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9498099"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9662394"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9714430"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9719626"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="71" type="ECO:0000305"/>
<sequence length="475" mass="53162" checksum="FBD00FCD334FB8AA" modified="1988-01-01" version="1" precursor="true">
MESKALLVLTLAVWLQSLTASRGGVAAADQRRDFIDIESKFALRTPEDTAEDTCHLIPGV
AESVATCHFNHSSKTFMVIHGWTVTGMYESWVPKLVAALYKREPDSNVIVVDWLSRAQEH
YPVSAGYTKLVGQDVARFINWMEEEFNYPLDNVHLLGYSLGAHAAGIAGSLTNKKVNRIT
GLDPAGPNFEYAEAPSRLSPDDADFVDVLHTFTRGSPGRSIGIQKPVGHVDIYPNGGTFQ
PGCNIGEAIRVIAERGLGDVDQLVKCSHERSIHLFIDSLLNEENPSKAYRCSSKEAFEKG
LCLSCRKNRCNNLGYEINKVRAKRSSKMYLKTRSQMPYKVFHYQVKIHFSGTESETHTNQ
AFEISLYGTVAESENIPFTLPEVSTNKTYSFLIYTEVDIGELLMLKLKWKSDSYFSWSDW
WSSPGFAIQKIRVKAGETQKKVIFCSREKVSHLQKGKAPAVFVKCHDKSLNKKSG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>